Loading…
Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients
Objective: To investigate the role of HLA-B and HLA-DR genes as contributors to genetic susceptibility and clinical expression of the spondyloarthropathies (SpA) in the Mexican population. Methods: The study included 172 patients with SpA (undifferentiated SpA 83, ankylosing spondylitis (AS) 64, and...
Saved in:
Published in: | Annals of the rheumatic diseases 2002-08, Vol.61 (8), p.714-717 |
---|---|
Main Authors: | , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-b610t-aabb5902283627c3d84c733c3896d872023952adf1da963365569eadaddd816b3 |
---|---|
cites | |
container_end_page | 717 |
container_issue | 8 |
container_start_page | 714 |
container_title | Annals of the rheumatic diseases |
container_volume | 61 |
creator | Vargas-Alarcón, G Londoño, J D Hernández-Pacheco, G Pacheco-Tena, C Castillo, E Cardiel, M H Granados, J Burgos-Vargas, R |
description | Objective: To investigate the role of HLA-B and HLA-DR genes as contributors to genetic susceptibility and clinical expression of the spondyloarthropathies (SpA) in the Mexican population. Methods: The study included 172 patients with SpA (undifferentiated SpA 83, ankylosing spondylitis (AS) 64, and reactive arthritis 25) and 99 healthy controls. The HLA-B and HLA-DR alleles were detected by the polymerase chain reaction with sequence-specific primers technique. Patient assessment included demographic data, diagnostic categories, and disease patterns. Statistical methods included the Mantel-Haenzel χ2 test, Fisher's exact test, and Woolf method for odds ratio (OR). Differences of continuous variables between HLA allele groups were calculated by Student's t test. Results: Increased frequencies of HLA-B27 (pCh10−3, OR=28.7), HLA-DR1 (pC=0.045, OR=2.77), and HLA-B15 (p=0.034, pC=NS, OR=2.04) alleles in the whole group were found. HLA-B27 strength of association (OR) was 41.4 in AS; 20.9 in undifferentiated SpA; 27.2 in reactive arthritis. HLA-DR1 and HLA-B15 were increased in undifferentiated SpA (pC=0.045, OR=2.98 and p=0.004, pC=NS, OR=2.75). By analysing 58 HLA-B27 negative patients it was found that HLA-B15 and HLA-DR1 associations with SpA were independent of HLA-B27; increased frequencies of HLA-B15 were found in the whole SpA group and in patients with undifferentiated SpA (pC=0.03, OR=3.09 and pCh0.01, OR=3.77) and of HLA-DR1 in the latter (p=0.04, pC=NS, OR=3.15). HLA-B27 positive patients were younger than HLA-B27 negative patients at onset (p=0.03), but HLA-DR1 positive patients were older than HLA-DR1 negative patients (p=0.03). Bath indices for disease activity and functioning were higher in HLA-B27 positive patients (p=0.006 and p=0.004 v HLA-B27 negative patients). In contrast, neither HLA-DR1 nor HLA-B15 influenced these indices. Conclusion: Apart from HLA-B27, there is a significant association of HLA-DR1 and HLA-B15 with SpA in Mexicans which is independent of B27. HLA-B27 is associated with younger age at onset and increased disease severity and HLA-DR1 with older age at onset. The strength of HLA-B15, HLA-B27, and HLA-DR1 associations varied in different forms of SpA. |
doi_str_mv | 10.1136/ard.61.8.714 |
format | article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1754177</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A90161585</galeid><sourcerecordid>A90161585</sourcerecordid><originalsourceid>FETCH-LOGICAL-b610t-aabb5902283627c3d84c733c3896d872023952adf1da963365569eadaddd816b3</originalsourceid><addsrcrecordid>eNp9klGPEyEQx4nReLX65rPZaNQXtzLLLrAvJrV3esaqF6PGN8IC21K3UGF7uX576bW5nqYxPMAMv_nPMAxCjwGPAAh9LYMeURjxEYPyDhpASXleYIrvogHGmORlTdkJehDjIpmYA7-PTqAAYJSxAfJnbWtUn_k2O5-O87eZdPr6dPo1mxlnYuZdFtdRmVVvG9vZfpP1_pqK5tKErZ1i48o7vem8DP08-JXs5zaFWpd9MldWSZcllzWujw_RvVZ20Tza70P0_d3Zt8l5Pv3y_sNkPM0bCrjPpWyaqsZFwQktmCKal4oRogivqeaswAWpq0LqFrSsKSG0qmhtpJZaaw60IUP0Zqe7WjdLo1XKHWQnVsEuZdgIL634-8bZuZj5SwGsKoGxJPBiLxD877WJvVja1IWuk874dRQMalyVdZHAZ_-AC78OLj0uaTHGy5JUJFFPd9RMdkZY1_qUVW0lxbjGQKHiVYJeHYG235Aq9M60Nrlv4_kRPC1tllYd4_fyKvgYg2lv2gFYbGdJpFkSFARPrysT_uR2Cw_wfngS8HwPyKhk1wbplI0HjjAOgItDnTb25urmXoZfgjLCKvH5x0TUp9XHn5OLixQ2RC93fLNc_L_EP7Xh6_U</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1777844353</pqid></control><display><type>article</type><title>Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients</title><source>PubMed (Medline)</source><creator>Vargas-Alarcón, G ; Londoño, J D ; Hernández-Pacheco, G ; Pacheco-Tena, C ; Castillo, E ; Cardiel, M H ; Granados, J ; Burgos-Vargas, R</creator><creatorcontrib>Vargas-Alarcón, G ; Londoño, J D ; Hernández-Pacheco, G ; Pacheco-Tena, C ; Castillo, E ; Cardiel, M H ; Granados, J ; Burgos-Vargas, R</creatorcontrib><description>Objective: To investigate the role of HLA-B and HLA-DR genes as contributors to genetic susceptibility and clinical expression of the spondyloarthropathies (SpA) in the Mexican population. Methods: The study included 172 patients with SpA (undifferentiated SpA 83, ankylosing spondylitis (AS) 64, and reactive arthritis 25) and 99 healthy controls. The HLA-B and HLA-DR alleles were detected by the polymerase chain reaction with sequence-specific primers technique. Patient assessment included demographic data, diagnostic categories, and disease patterns. Statistical methods included the Mantel-Haenzel χ2 test, Fisher's exact test, and Woolf method for odds ratio (OR). Differences of continuous variables between HLA allele groups were calculated by Student's t test. Results: Increased frequencies of HLA-B27 (pCh10−3, OR=28.7), HLA-DR1 (pC=0.045, OR=2.77), and HLA-B15 (p=0.034, pC=NS, OR=2.04) alleles in the whole group were found. HLA-B27 strength of association (OR) was 41.4 in AS; 20.9 in undifferentiated SpA; 27.2 in reactive arthritis. HLA-DR1 and HLA-B15 were increased in undifferentiated SpA (pC=0.045, OR=2.98 and p=0.004, pC=NS, OR=2.75). By analysing 58 HLA-B27 negative patients it was found that HLA-B15 and HLA-DR1 associations with SpA were independent of HLA-B27; increased frequencies of HLA-B15 were found in the whole SpA group and in patients with undifferentiated SpA (pC=0.03, OR=3.09 and pCh0.01, OR=3.77) and of HLA-DR1 in the latter (p=0.04, pC=NS, OR=3.15). HLA-B27 positive patients were younger than HLA-B27 negative patients at onset (p=0.03), but HLA-DR1 positive patients were older than HLA-DR1 negative patients (p=0.03). Bath indices for disease activity and functioning were higher in HLA-B27 positive patients (p=0.006 and p=0.004 v HLA-B27 negative patients). In contrast, neither HLA-DR1 nor HLA-B15 influenced these indices. Conclusion: Apart from HLA-B27, there is a significant association of HLA-DR1 and HLA-B15 with SpA in Mexicans which is independent of B27. HLA-B27 is associated with younger age at onset and increased disease severity and HLA-DR1 with older age at onset. The strength of HLA-B15, HLA-B27, and HLA-DR1 associations varied in different forms of SpA.</description><identifier>ISSN: 0003-4967</identifier><identifier>EISSN: 1468-2060</identifier><identifier>DOI: 10.1136/ard.61.8.714</identifier><identifier>PMID: 12117677</identifier><identifier>CODEN: ARDIAO</identifier><language>eng</language><publisher>London: BMJ Publishing Group Ltd and European League Against Rheumatism</publisher><subject>Adult ; aetiological fraction ; Age of Onset ; ankylosing spondylitis ; BASDAI ; BASFI ; Bath Ankylosing Disease Activity Index ; Bath Ankylosing Spondylitis Functional Index ; Biological and medical sciences ; Confidence intervals ; Disease ; Disease susceptibility ; Diseases of the osteoarticular system ; Extended Report ; Female ; Gene Frequency ; Genes ; Genetic aspects ; Genetic Predisposition to Disease ; genetics ; Histocompatibility antigens ; HLA ; HLA histocompatibility antigens ; HLA-B Antigens - genetics ; HLA-B15 Antigen ; HLA-B27 Antigen - genetics ; HLA-DR1 Antigen - genetics ; Humans ; Inflammatory joint diseases ; major histocompatibility complex ; Male ; Medical sciences ; Mexican population ; Mexicans ; Mexico - ethnology ; MHC ; odds ratio ; ReA ; reactive arthritis ; SpA ; Spondylitis, Ankylosing - ethnology ; Spondylitis, Ankylosing - genetics ; Spondyloarthropathies ; Studies</subject><ispartof>Annals of the rheumatic diseases, 2002-08, Vol.61 (8), p.714-717</ispartof><rights>Copyright 2002 by Annals of the Rheumatic Diseases</rights><rights>2002 INIST-CNRS</rights><rights>COPYRIGHT 2002 BMJ Publishing Group Ltd.</rights><rights>Copyright: 2002 Copyright 2002 by Annals of the Rheumatic Diseases</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b610t-aabb5902283627c3d84c733c3896d872023952adf1da963365569eadaddd816b3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1754177/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC1754177/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=13781102$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12117677$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vargas-Alarcón, G</creatorcontrib><creatorcontrib>Londoño, J D</creatorcontrib><creatorcontrib>Hernández-Pacheco, G</creatorcontrib><creatorcontrib>Pacheco-Tena, C</creatorcontrib><creatorcontrib>Castillo, E</creatorcontrib><creatorcontrib>Cardiel, M H</creatorcontrib><creatorcontrib>Granados, J</creatorcontrib><creatorcontrib>Burgos-Vargas, R</creatorcontrib><title>Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients</title><title>Annals of the rheumatic diseases</title><addtitle>Ann Rheum Dis</addtitle><description>Objective: To investigate the role of HLA-B and HLA-DR genes as contributors to genetic susceptibility and clinical expression of the spondyloarthropathies (SpA) in the Mexican population. Methods: The study included 172 patients with SpA (undifferentiated SpA 83, ankylosing spondylitis (AS) 64, and reactive arthritis 25) and 99 healthy controls. The HLA-B and HLA-DR alleles were detected by the polymerase chain reaction with sequence-specific primers technique. Patient assessment included demographic data, diagnostic categories, and disease patterns. Statistical methods included the Mantel-Haenzel χ2 test, Fisher's exact test, and Woolf method for odds ratio (OR). Differences of continuous variables between HLA allele groups were calculated by Student's t test. Results: Increased frequencies of HLA-B27 (pCh10−3, OR=28.7), HLA-DR1 (pC=0.045, OR=2.77), and HLA-B15 (p=0.034, pC=NS, OR=2.04) alleles in the whole group were found. HLA-B27 strength of association (OR) was 41.4 in AS; 20.9 in undifferentiated SpA; 27.2 in reactive arthritis. HLA-DR1 and HLA-B15 were increased in undifferentiated SpA (pC=0.045, OR=2.98 and p=0.004, pC=NS, OR=2.75). By analysing 58 HLA-B27 negative patients it was found that HLA-B15 and HLA-DR1 associations with SpA were independent of HLA-B27; increased frequencies of HLA-B15 were found in the whole SpA group and in patients with undifferentiated SpA (pC=0.03, OR=3.09 and pCh0.01, OR=3.77) and of HLA-DR1 in the latter (p=0.04, pC=NS, OR=3.15). HLA-B27 positive patients were younger than HLA-B27 negative patients at onset (p=0.03), but HLA-DR1 positive patients were older than HLA-DR1 negative patients (p=0.03). Bath indices for disease activity and functioning were higher in HLA-B27 positive patients (p=0.006 and p=0.004 v HLA-B27 negative patients). In contrast, neither HLA-DR1 nor HLA-B15 influenced these indices. Conclusion: Apart from HLA-B27, there is a significant association of HLA-DR1 and HLA-B15 with SpA in Mexicans which is independent of B27. HLA-B27 is associated with younger age at onset and increased disease severity and HLA-DR1 with older age at onset. The strength of HLA-B15, HLA-B27, and HLA-DR1 associations varied in different forms of SpA.</description><subject>Adult</subject><subject>aetiological fraction</subject><subject>Age of Onset</subject><subject>ankylosing spondylitis</subject><subject>BASDAI</subject><subject>BASFI</subject><subject>Bath Ankylosing Disease Activity Index</subject><subject>Bath Ankylosing Spondylitis Functional Index</subject><subject>Biological and medical sciences</subject><subject>Confidence intervals</subject><subject>Disease</subject><subject>Disease susceptibility</subject><subject>Diseases of the osteoarticular system</subject><subject>Extended Report</subject><subject>Female</subject><subject>Gene Frequency</subject><subject>Genes</subject><subject>Genetic aspects</subject><subject>Genetic Predisposition to Disease</subject><subject>genetics</subject><subject>Histocompatibility antigens</subject><subject>HLA</subject><subject>HLA histocompatibility antigens</subject><subject>HLA-B Antigens - genetics</subject><subject>HLA-B15 Antigen</subject><subject>HLA-B27 Antigen - genetics</subject><subject>HLA-DR1 Antigen - genetics</subject><subject>Humans</subject><subject>Inflammatory joint diseases</subject><subject>major histocompatibility complex</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Mexican population</subject><subject>Mexicans</subject><subject>Mexico - ethnology</subject><subject>MHC</subject><subject>odds ratio</subject><subject>ReA</subject><subject>reactive arthritis</subject><subject>SpA</subject><subject>Spondylitis, Ankylosing - ethnology</subject><subject>Spondylitis, Ankylosing - genetics</subject><subject>Spondyloarthropathies</subject><subject>Studies</subject><issn>0003-4967</issn><issn>1468-2060</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2002</creationdate><recordtype>article</recordtype><recordid>eNp9klGPEyEQx4nReLX65rPZaNQXtzLLLrAvJrV3esaqF6PGN8IC21K3UGF7uX576bW5nqYxPMAMv_nPMAxCjwGPAAh9LYMeURjxEYPyDhpASXleYIrvogHGmORlTdkJehDjIpmYA7-PTqAAYJSxAfJnbWtUn_k2O5-O87eZdPr6dPo1mxlnYuZdFtdRmVVvG9vZfpP1_pqK5tKErZ1i48o7vem8DP08-JXs5zaFWpd9MldWSZcllzWujw_RvVZ20Tza70P0_d3Zt8l5Pv3y_sNkPM0bCrjPpWyaqsZFwQktmCKal4oRogivqeaswAWpq0LqFrSsKSG0qmhtpJZaaw60IUP0Zqe7WjdLo1XKHWQnVsEuZdgIL634-8bZuZj5SwGsKoGxJPBiLxD877WJvVja1IWuk874dRQMalyVdZHAZ_-AC78OLj0uaTHGy5JUJFFPd9RMdkZY1_qUVW0lxbjGQKHiVYJeHYG235Aq9M60Nrlv4_kRPC1tllYd4_fyKvgYg2lv2gFYbGdJpFkSFARPrysT_uR2Cw_wfngS8HwPyKhk1wbplI0HjjAOgItDnTb25urmXoZfgjLCKvH5x0TUp9XHn5OLixQ2RC93fLNc_L_EP7Xh6_U</recordid><startdate>20020801</startdate><enddate>20020801</enddate><creator>Vargas-Alarcón, G</creator><creator>Londoño, J D</creator><creator>Hernández-Pacheco, G</creator><creator>Pacheco-Tena, C</creator><creator>Castillo, E</creator><creator>Cardiel, M H</creator><creator>Granados, J</creator><creator>Burgos-Vargas, R</creator><general>BMJ Publishing Group Ltd and European League Against Rheumatism</general><general>BMJ</general><general>BMJ Publishing Group Ltd</general><general>BMJ Publishing Group LTD</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88I</scope><scope>8AF</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BTHHO</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>K9-</scope><scope>K9.</scope><scope>LK8</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20020801</creationdate><title>Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients</title><author>Vargas-Alarcón, G ; Londoño, J D ; Hernández-Pacheco, G ; Pacheco-Tena, C ; Castillo, E ; Cardiel, M H ; Granados, J ; Burgos-Vargas, R</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b610t-aabb5902283627c3d84c733c3896d872023952adf1da963365569eadaddd816b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2002</creationdate><topic>Adult</topic><topic>aetiological fraction</topic><topic>Age of Onset</topic><topic>ankylosing spondylitis</topic><topic>BASDAI</topic><topic>BASFI</topic><topic>Bath Ankylosing Disease Activity Index</topic><topic>Bath Ankylosing Spondylitis Functional Index</topic><topic>Biological and medical sciences</topic><topic>Confidence intervals</topic><topic>Disease</topic><topic>Disease susceptibility</topic><topic>Diseases of the osteoarticular system</topic><topic>Extended Report</topic><topic>Female</topic><topic>Gene Frequency</topic><topic>Genes</topic><topic>Genetic aspects</topic><topic>Genetic Predisposition to Disease</topic><topic>genetics</topic><topic>Histocompatibility antigens</topic><topic>HLA</topic><topic>HLA histocompatibility antigens</topic><topic>HLA-B Antigens - genetics</topic><topic>HLA-B15 Antigen</topic><topic>HLA-B27 Antigen - genetics</topic><topic>HLA-DR1 Antigen - genetics</topic><topic>Humans</topic><topic>Inflammatory joint diseases</topic><topic>major histocompatibility complex</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Mexican population</topic><topic>Mexicans</topic><topic>Mexico - ethnology</topic><topic>MHC</topic><topic>odds ratio</topic><topic>ReA</topic><topic>reactive arthritis</topic><topic>SpA</topic><topic>Spondylitis, Ankylosing - ethnology</topic><topic>Spondylitis, Ankylosing - genetics</topic><topic>Spondyloarthropathies</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vargas-Alarcón, G</creatorcontrib><creatorcontrib>Londoño, J D</creatorcontrib><creatorcontrib>Hernández-Pacheco, G</creatorcontrib><creatorcontrib>Pacheco-Tena, C</creatorcontrib><creatorcontrib>Castillo, E</creatorcontrib><creatorcontrib>Cardiel, M H</creatorcontrib><creatorcontrib>Granados, J</creatorcontrib><creatorcontrib>Burgos-Vargas, R</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>BMJ Journals</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Science Database</collection><collection>ProQuest Biological Science Journals</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Annals of the rheumatic diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vargas-Alarcón, G</au><au>Londoño, J D</au><au>Hernández-Pacheco, G</au><au>Pacheco-Tena, C</au><au>Castillo, E</au><au>Cardiel, M H</au><au>Granados, J</au><au>Burgos-Vargas, R</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients</atitle><jtitle>Annals of the rheumatic diseases</jtitle><addtitle>Ann Rheum Dis</addtitle><date>2002-08-01</date><risdate>2002</risdate><volume>61</volume><issue>8</issue><spage>714</spage><epage>717</epage><pages>714-717</pages><issn>0003-4967</issn><eissn>1468-2060</eissn><coden>ARDIAO</coden><abstract>Objective: To investigate the role of HLA-B and HLA-DR genes as contributors to genetic susceptibility and clinical expression of the spondyloarthropathies (SpA) in the Mexican population. Methods: The study included 172 patients with SpA (undifferentiated SpA 83, ankylosing spondylitis (AS) 64, and reactive arthritis 25) and 99 healthy controls. The HLA-B and HLA-DR alleles were detected by the polymerase chain reaction with sequence-specific primers technique. Patient assessment included demographic data, diagnostic categories, and disease patterns. Statistical methods included the Mantel-Haenzel χ2 test, Fisher's exact test, and Woolf method for odds ratio (OR). Differences of continuous variables between HLA allele groups were calculated by Student's t test. Results: Increased frequencies of HLA-B27 (pCh10−3, OR=28.7), HLA-DR1 (pC=0.045, OR=2.77), and HLA-B15 (p=0.034, pC=NS, OR=2.04) alleles in the whole group were found. HLA-B27 strength of association (OR) was 41.4 in AS; 20.9 in undifferentiated SpA; 27.2 in reactive arthritis. HLA-DR1 and HLA-B15 were increased in undifferentiated SpA (pC=0.045, OR=2.98 and p=0.004, pC=NS, OR=2.75). By analysing 58 HLA-B27 negative patients it was found that HLA-B15 and HLA-DR1 associations with SpA were independent of HLA-B27; increased frequencies of HLA-B15 were found in the whole SpA group and in patients with undifferentiated SpA (pC=0.03, OR=3.09 and pCh0.01, OR=3.77) and of HLA-DR1 in the latter (p=0.04, pC=NS, OR=3.15). HLA-B27 positive patients were younger than HLA-B27 negative patients at onset (p=0.03), but HLA-DR1 positive patients were older than HLA-DR1 negative patients (p=0.03). Bath indices for disease activity and functioning were higher in HLA-B27 positive patients (p=0.006 and p=0.004 v HLA-B27 negative patients). In contrast, neither HLA-DR1 nor HLA-B15 influenced these indices. Conclusion: Apart from HLA-B27, there is a significant association of HLA-DR1 and HLA-B15 with SpA in Mexicans which is independent of B27. HLA-B27 is associated with younger age at onset and increased disease severity and HLA-DR1 with older age at onset. The strength of HLA-B15, HLA-B27, and HLA-DR1 associations varied in different forms of SpA.</abstract><cop>London</cop><pub>BMJ Publishing Group Ltd and European League Against Rheumatism</pub><pmid>12117677</pmid><doi>10.1136/ard.61.8.714</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0003-4967 |
ispartof | Annals of the rheumatic diseases, 2002-08, Vol.61 (8), p.714-717 |
issn | 0003-4967 1468-2060 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_1754177 |
source | PubMed (Medline) |
subjects | Adult aetiological fraction Age of Onset ankylosing spondylitis BASDAI BASFI Bath Ankylosing Disease Activity Index Bath Ankylosing Spondylitis Functional Index Biological and medical sciences Confidence intervals Disease Disease susceptibility Diseases of the osteoarticular system Extended Report Female Gene Frequency Genes Genetic aspects Genetic Predisposition to Disease genetics Histocompatibility antigens HLA HLA histocompatibility antigens HLA-B Antigens - genetics HLA-B15 Antigen HLA-B27 Antigen - genetics HLA-DR1 Antigen - genetics Humans Inflammatory joint diseases major histocompatibility complex Male Medical sciences Mexican population Mexicans Mexico - ethnology MHC odds ratio ReA reactive arthritis SpA Spondylitis, Ankylosing - ethnology Spondylitis, Ankylosing - genetics Spondyloarthropathies Studies |
title | Effect of HLA-B and HLA-DR genes on susceptibility to and severity of spondyloarthropathies in Mexican patients |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T10%3A42%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effect%20of%20HLA-B%20and%20HLA-DR%20genes%20on%20susceptibility%20to%20and%20severity%20of%20spondyloarthropathies%20in%20Mexican%20patients&rft.jtitle=Annals%20of%20the%20rheumatic%20diseases&rft.au=Vargas-Alarc%C3%B3n,%20G&rft.date=2002-08-01&rft.volume=61&rft.issue=8&rft.spage=714&rft.epage=717&rft.pages=714-717&rft.issn=0003-4967&rft.eissn=1468-2060&rft.coden=ARDIAO&rft_id=info:doi/10.1136/ard.61.8.714&rft_dat=%3Cgale_pubme%3EA90161585%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-b610t-aabb5902283627c3d84c733c3896d872023952adf1da963365569eadaddd816b3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1777844353&rft_id=info:pmid/12117677&rft_galeid=A90161585&rfr_iscdi=true |